Reviva Pharmaceuticals shares are trading higher after the company announced its pivotal Phase 3 RECOVER trial evaluating the efficacy, safety and tolerability successfully met its primary endpoint.

Reviva Pharmaceuticals Holdings Inc. Ordinary Shares -9.62% Post

Reviva Pharmaceuticals Holdings Inc. Ordinary Shares

RVPH

1.08

1.08

-9.62%

0.00% Post

Reviva Pharmaceuticals shares are trading higher after the company announced its pivotal Phase 3 RECOVER trial evaluating the efficacy, safety and tolerability successfully met its primary endpoint.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via